DE60128448D1 - Verwendung von isothiazolderivaten als ureaseinhibitoren zur behandlung von helicobacter pylori verursachte gastrointestinale krankheiten - Google Patents

Verwendung von isothiazolderivaten als ureaseinhibitoren zur behandlung von helicobacter pylori verursachte gastrointestinale krankheiten

Info

Publication number
DE60128448D1
DE60128448D1 DE60128448T DE60128448T DE60128448D1 DE 60128448 D1 DE60128448 D1 DE 60128448D1 DE 60128448 T DE60128448 T DE 60128448T DE 60128448 T DE60128448 T DE 60128448T DE 60128448 D1 DE60128448 D1 DE 60128448D1
Authority
DE
Germany
Prior art keywords
helicobacter pylori
gastrointestinal diseases
treatment
urease inhibitors
urease
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE60128448T
Other languages
English (en)
Other versions
DE60128448T2 (de
Inventor
Masahiro Kajiwara
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Otsuka Pharmaceutical Co Ltd
Original Assignee
Otsuka Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Otsuka Pharmaceutical Co Ltd filed Critical Otsuka Pharmaceutical Co Ltd
Publication of DE60128448D1 publication Critical patent/DE60128448D1/de
Application granted granted Critical
Publication of DE60128448T2 publication Critical patent/DE60128448T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D275/00—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings
    • C07D275/04—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings condensed with carbocyclic rings or ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/428—Thiazoles condensed with carbocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
DE60128448T 2000-03-07 2001-03-02 Verwendung von isothiazolderivaten als ureaseinhibitoren zur behandlung von helicobacter pylori verursachte gastrointestinale krankheiten Expired - Fee Related DE60128448T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2000062012 2000-03-07
JP2000062012A JP2001247462A (ja) 2000-03-07 2000-03-07 ウレアーゼ阻害剤
PCT/JP2001/001618 WO2001066112A1 (fr) 2000-03-07 2001-03-02 Inhibiteurs d'urease

Publications (2)

Publication Number Publication Date
DE60128448D1 true DE60128448D1 (de) 2007-06-28
DE60128448T2 DE60128448T2 (de) 2008-01-17

Family

ID=18582077

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60128448T Expired - Fee Related DE60128448T2 (de) 2000-03-07 2001-03-02 Verwendung von isothiazolderivaten als ureaseinhibitoren zur behandlung von helicobacter pylori verursachte gastrointestinale krankheiten

Country Status (13)

Country Link
US (2) US20030060482A1 (de)
EP (1) EP1262181B1 (de)
JP (1) JP2001247462A (de)
KR (1) KR20030016235A (de)
CN (1) CN1171589C (de)
AT (1) ATE362366T1 (de)
AU (2) AU2001236052B2 (de)
CA (1) CA2400527A1 (de)
DE (1) DE60128448T2 (de)
DK (1) DK1262181T3 (de)
ES (1) ES2284619T3 (de)
PT (1) PT1262181E (de)
WO (1) WO2001066112A1 (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CZ2006427A3 (cs) 2003-12-29 2006-11-15 Sepracor Inc. Pyrrolové a pyrazolové inhibitory DAAO
CN1922157B (zh) 2003-12-29 2011-01-12 塞普拉科公司 苯并[d]异噁唑-3-醇DAAO抑制剂
JP2009500425A (ja) 2005-07-06 2009-01-08 セプラコア インコーポレーテッド エスゾピクロン及びトランス４−（３，４−ジクロロフェニル）−１，２，３，４−テトラヒドロ−ｎ−メチル−１−ナフタレンアミン又はトランス４−（３，４−ジクロロフェニル）−１，２，３，４−テトラヒドロ−１−ナフタレンアミンの組み合わせ、並びに閉経期並びに気分、不安、及び認知障害の治療方法
ES2566479T3 (es) 2006-01-06 2016-04-13 Sunovion Pharmaceuticals Inc. Inhibidores de reabsorción de monoamina con base en tetralona
US20070203111A1 (en) 2006-01-06 2007-08-30 Sepracor Inc. Cycloalkylamines as monoamine reuptake inhibitors
EP2816024B8 (de) 2006-03-31 2018-04-04 Sunovion Pharmaceuticals Inc. Chirale Amine
EP2061472A4 (de) * 2006-05-22 2010-12-22 Thioredoxin Systems Ab Bakterielle thioredoxin-reductase-hemmer und anwendungsverfahren dafür
US7884124B2 (en) 2006-06-30 2011-02-08 Sepracor Inc. Fluoro-substituted inhibitors of D-amino acid oxidase
US7902252B2 (en) 2007-01-18 2011-03-08 Sepracor, Inc. Inhibitors of D-amino acid oxidase
JP5420534B2 (ja) 2007-05-31 2014-02-19 サノビオン ファーマシューティカルズ インク モノアミン再取り込み阻害薬としてのフェニル置換シクロアルキルアミン
CN101560189B (zh) * 2009-05-20 2011-02-16 南京大学 甲硝唑和取代水杨酸的复合物及其制法与用途
EP2925734B1 (de) * 2012-11-28 2016-10-05 Rohm and Haas Company Verfahren zur herstellung von 2-alkyl-1,2-benzisothiazolin-3-onen
CN103012309A (zh) * 2013-01-23 2013-04-03 寿光新泰精细化工有限公司 一种2-甲基-1,2-苯并异噻唑啉-3-酮的合成方法
US10058542B1 (en) 2014-09-12 2018-08-28 Thioredoxin Systems Ab Composition comprising selenazol or thiazolone derivatives and silver and method of treatment therewith
WO2016085655A1 (en) * 2014-11-26 2016-06-02 Rohm And Haas Company Method for preparation of 2-methyl-1,2-benzisothiazolin-3-one
GB2544109A (en) * 2015-11-06 2017-05-10 Visa Europe Ltd Transaction authorisation
CN105753805A (zh) * 2016-03-31 2016-07-13 寿光新泰精细化工有限公司 一种1,2-苯并异噻唑-3-酮的提纯方法
CN105801516B (zh) * 2016-04-28 2018-05-04 大丰跃龙化学有限公司 一种1,2-苯并异噻唑啉-3-酮提纯工艺

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS62273903A (ja) * 1986-05-22 1987-11-28 Kurita Water Ind Ltd 防腐剤
JPH0477476A (ja) * 1990-07-19 1992-03-11 Sankyo Co Ltd 抗潰瘍剤
JP2839827B2 (ja) * 1993-10-05 1998-12-16 大塚製薬株式会社 ウレアーゼ阻害剤
JPH08314097A (ja) * 1995-05-15 1996-11-29 Fuji Photo Film Co Ltd ハロゲン化銀写真感光材料の収納保存方法
JPH10109912A (ja) * 1996-10-04 1998-04-28 Akio Suganuma 抗菌組成物
JP3940201B2 (ja) * 1997-05-20 2007-07-04 大塚製薬株式会社 ３，３’−ジチオジベンゾヒドロキサム酸

Also Published As

Publication number Publication date
CA2400527A1 (en) 2001-09-13
US20030060482A1 (en) 2003-03-27
US20040058952A1 (en) 2004-03-25
JP2001247462A (ja) 2001-09-11
CN1171589C (zh) 2004-10-20
CN1422155A (zh) 2003-06-04
KR20030016235A (ko) 2003-02-26
DE60128448T2 (de) 2008-01-17
AU3605201A (en) 2001-09-17
PT1262181E (pt) 2007-06-27
DK1262181T3 (da) 2007-09-10
ATE362366T1 (de) 2007-06-15
WO2001066112A1 (fr) 2001-09-13
EP1262181A1 (de) 2002-12-04
EP1262181B1 (de) 2007-05-16
ES2284619T3 (es) 2007-11-16
EP1262181A4 (de) 2004-10-13
AU2001236052B2 (en) 2005-04-28

Similar Documents

Publication Publication Date Title
DE60128448D1 (de) Verwendung von isothiazolderivaten als ureaseinhibitoren zur behandlung von helicobacter pylori verursachte gastrointestinale krankheiten
NZ505968A (en) Sulfonylamino derivatives which inhibit matrix- degrading metallproteinases
EA200601830A1 (ru) Ортозамещённые арильные или гетероарильные амидные соединения
ATE312100T1 (de) Chinuclidin-verbindungen und medikamente die diese als aktive wirkstoffe enthalten
EP1620108A4 (de) Pyrazol-amin-verbindungen als kinase-hemmer
DK1163208T3 (da) Caspaseinhibitorer og anvendelser deraf
CY1109245T1 (el) Ενωσεις χρησιμες στην θεραπεια ανθρακα και στην αναστολη θανατηφορου παραγοντα
DE602004011255D1 (de) Phosphinsäurederivate, inhibitoren von beta-sekretase zur behandlung von alzheimer-krankheit
ATE404541T1 (de) Xanthinoxidaseinhibitoren
ATE380816T1 (de) Substituierte imidazopyrimidine zur prävention und behandlung von krebs
ATE239741T1 (de) Derivate der phosphonsäure zur inhibierung von carboxypeptidase b
ATE332697T1 (de) Cyanidinmischung zur behandlung von dickdarmkrebs
NO985202D0 (no) Anti-heliobacter pylori-preparater inneholdende 1-metylcarbapenemderivater
ATE240957T1 (de) Optisch aktive pyrrolopyridazin-derivate
ATE535242T1 (de) Medizinische zusammensetzung zur prävention des übergangs zu einer operativen behandlung bei prostatahypertrophie
TW200730177A (en) 4 anilino-3-quinolinecarbonitriles for the treatment of cancer
NO20061152L (no) Ny fremgangsmate for syntese av N-(S)-1-karboksybuty)-(S)-alanin og anvendelse derav for a syntetisere perindopril
NO20023771D0 (no) Pyrrolopyridazinforbindelse
MXPA06000651A (es) Uso de derivados de indazol para el tratamiento de dolor neuropatico.
ATE380028T1 (de) Mittel zur anregung des appetits und mittel zur behandlung von anorexie
EA200970812A1 (ru) Способ лечения и предупреждения артрита
ATE359778T1 (de) Mittel zur behandlung von myelopathie

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee